Risk of Pancreatic Cancer and Use of Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes: A Propensity Score-Matching Analysis

BACKGROUND: The effects of dipeptidyl peptidase 4 (DPP-4) inhibitors over the course of long-term treatment remain unclear, and concerns have been raised regarding the role of DPP-4 inhibitors in carcinogenesis in the pancreas. Earlier studies of pancreatic adverse events have reported conflicting r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Mee Kyoung, Han, Kyungdo, Kwon, Hyuk-Sang, Yoo, Soon Jib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475964/
https://www.ncbi.nlm.nih.gov/pubmed/37469033
http://dx.doi.org/10.3803/EnM.2023.1737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475964/
https://www.ncbi.nlm.nih.gov/pubmed/37469033
http://dx.doi.org/10.3803/EnM.2023.1737

Ejemplares similares